Ads

 

Ads

 

Ads

 

World Top 1,000 Companies as of 2026

World Top 1,000 Companies by Market Cap from Value.Today : 2026

World Top 1,000 Companies by Market Cap. World Biggest 1,000 Companies by Market Cap. NVIDIA which is leader in Chips manufacturing became World Number 1 Company as of August-2026. To be part of World Top 1,000 Companies, a company minimum market cap or net worth to be 25.71 billion USD plus.

Chenbro Micom

World Rank (Aug-2026)
5,606
Market Cap (Aug-2026)
2.496 Billion USD
World Rank (Jan-05-2024)
8,650
Market Cap (Jan-05-2024)
0.987 Billion USD
World Rank (Jul-30-2023)
9,635
Market Cap (Jul-30-2023)
0.842 Billion USD
World Rank (Dec-25-2022)
15,928
Market Cap (Dec-25-2022)
0.291 Billion USD
World Rank (Jan-07-2022)
15,994
Market Cap (Jan-07-2022)
0.34 Billion USD
Headquarters Country

Fuji Oil Holdings

World Rank (Aug-2026)
5,607
Market Cap (Aug-2026)
2.495 Billion USD
World Rank (Jan-05-2024)
6,862
Market Cap (Jan-05-2024)
1.469 Billion USD
World Rank (Jul-30-2023)
7,850
Market Cap (Jul-30-2023)
1.200 Billion USD
World Rank (Dec-25-2022)
7,149
Market Cap (Dec-25-2022)
1.311 Billion USD
World Rank (Jan-07-2022)
6,807
Market Cap (Jan-07-2022)
1.75 Billion USD
Annual Revenue in USD
3,166 Million USD
Annual Net Income in USD
84 Million USD
Annual Results for Period Ending
Mar-2022 ending year
Headquarters Country
Company Profile

Fuji Oil Holdings is a Holding company with business in three fields they are vegetable, oils and fats, industrial chocolate, emulsified and fermented ingredients and soy-based ingredients. The company annual revenue is 364,779 million JPY and annual net income is 11,015 million JPY as on 2021. The headquarters is in Japan.

Lakala Payment Corporation

World Rank (Aug-2026)
5,608
Market Cap (Aug-2026)
2.494 Billion USD
World Rank (Jan-05-2024)
6,181
Market Cap (Jan-05-2024)
1.746 Billion USD
World Rank (Jul-30-2023)
5,430
Market Cap (Jul-30-2023)
2.186 Billion USD
World Rank (Dec-25-2022)
5,696
Market Cap (Dec-25-2022)
1.859 Billion USD
World Rank (Jan-07-2022)
4,248
Market Cap (Jan-07-2022)
3.61 Billion USD
Annual Revenue in USD
970 Million USD
Annual Net Income in USD
159 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Headquarters Country

Nippon Shokubai

World Rank (Aug-2026)
5,609
Market Cap (Aug-2026)
2.492 Billion USD
World Rank (Jan-05-2024)
6,843
Market Cap (Jan-05-2024)
1.474 Billion USD
World Rank (Jul-30-2023)
6,831
Market Cap (Jul-30-2023)
1.516 Billion USD
World Rank (Dec-25-2022)
6,311
Market Cap (Dec-25-2022)
1.594 Billion USD
World Rank (Jan-07-2022)
6,602
Market Cap (Jan-07-2022)
1.85 Billion USD
Annual Revenue in USD
2,695 Million USD
Annual Net Income in USD
173 Million USD
Annual Results for Period Ending
Mar-2022 ending year
Headquarters Country
Company Profile
Chemicals and synthetic resins manufacturing company with headquarters is in Japan.

UFP Technologies

World Rank (Aug-2026)
5,610
Market Cap (Aug-2026)
2.492 Billion USD
World Rank (Jan-05-2024)
7,568
Market Cap (Jan-05-2024)
1.243 Billion USD
World Rank (Jul-30-2023)
7,001
Market Cap (Jul-30-2023)
1.456 Billion USD
World Rank (Dec-25-2022)
9,077
Market Cap (Dec-25-2022)
0.876 Billion USD
World Rank (Jan-07-2022)
12,895
Market Cap (Jan-07-2022)
0.55 Billion USD
Annual Revenue in USD
603 Million USD
Annual Operating Income in USD
92 Million USD
Annual Net Income in USD
68 Million USD
Annual Results for Period Ending
For year ending December-2025
Headquarters Country
Company Profile
UFP Technologies is primarily a medical designer and manufacturer company of custom devices, sub assemblies, components and packaging utilizing highly specialized foams, films and plastics. It is diversified in providing highly engineered products and components to customers in the aerospace, defense, automotive, consumer, electronics and industrial markets. The headquarters is in USA.

Deepak Nitrite

World Rank (Aug-2026)
5,611
Market Cap (Aug-2026)
2.491 Billion USD
World Rank (Jan-05-2024)
3,500
Market Cap (Jan-05-2024)
4.010 Billion USD
World Rank (Jul-30-2023)
4,041
Market Cap (Jul-30-2023)
3.336 Billion USD
World Rank (Dec-25-2022)
3,890
Market Cap (Dec-25-2022)
3.217 Billion USD
World Rank (Jan-07-2022)
3,491
Market Cap (Jan-07-2022)
4.63 Billion USD
Annual Revenue in USD
848 Million USD
Annual Net Income in USD
134 Million USD
Annual Results for Period Ending
Mar-2022 ending year
Headquarters Country
Stock Category
Company Profile

Deepak Nitrite develops advanced intermediates which requires complex chemistry and engineering company. The company has commercial production of intermediates for Agrochemicals, Dyes, Pharmaceuticals, stainless steel and glass lined reactors along with distillation columns for gas and liquid raw materials and is fully-equipped with advanced instruments, DCS (Distributed Control system) and utilities like chilled brine, low pressure steam, cooling water, temper water and more. The company annual revenue is 43,597 million INR and annul net income is 7,758 million INR as on 2021.

Calix Inc

World Rank (Aug-2026)
5,612
Market Cap (Aug-2026)
2.490 Billion USD
World Rank (Jan-05-2024)
4,473
Market Cap (Jan-05-2024)
2.920 Billion USD
World Rank (Jul-30-2023)
4,429
Market Cap (Jul-30-2023)
2.929 Billion USD
World Rank (Dec-25-2022)
3,026
Market Cap (Dec-25-2022)
4.415 Billion USD
World Rank (Jan-07-2022)
4,061
Market Cap (Jan-07-2022)
3.81 Billion USD
Annual Revenue in USD
1,000 Million USD
Annual Operating Income in USD
21 Million USD
Annual Net Income in USD
18 Million USD
Annual Results for Period Ending
For year ending December-2025
Headquarters Country
Company Profile

Calix is a Cloud and Software Platforms company enable service providers of all types and sizes to innovate, transform and optimize their business models, rapidly deploy new services. The headquarters is in USA.

Facts About Company

Calix company annual revenue was 867 million USD, annual operating income was 52 million USD and annual net income was 41 million USD for year ending Dec-2022.

Calix had 954 employees as on 2021.

Alfresa Holdings Corporation

World Rank (Aug-2026)
5,613
Market Cap (Aug-2026)
2.489 Billion USD
World Rank (Jan-05-2024)
4,268
Market Cap (Jan-05-2024)
3.106 Billion USD
World Rank (Jul-30-2023)
4,263
Market Cap (Jul-30-2023)
3.089 Billion USD
World Rank (Dec-25-2022)
5,180
Market Cap (Dec-25-2022)
2.159 Billion USD
World Rank (Jan-07-2022)
5,016
Market Cap (Jan-07-2022)
2.86 Billion USD
Annual Revenue in USD
18,867 Million USD
Annual Net Income in USD
235 Million USD
Annual Results for Period Ending
Mar-2022 ending year
Headquarters Country
Company Profile
ALFRESA HOLDINGS CORPORATION deals with wholesaling, manufacturing, marketing and import/export of pharmaceuticals, diagnostic reagents, medical devices/equipment, etc., and operating dispensing pharmacies and conducting related businesses. The company annual revenue is 2,698.5 billion JPY, annual net income is 40.2 billion JPY, annual operating income is 47.6 billion JPY, total assets is 1,351.6 billion JPY, total liabilities is 876.7 billion JPY, total equity is 473.7 billion JPY as on 2020. The headquarters is in Japan.

Sichuan Expressway Company

World Rank (Aug-2026)
5,614
Market Cap (Aug-2026)
2.489 Billion USD
World Rank (Jan-05-2024)
6,457
Market Cap (Jan-05-2024)
1.625 Billion USD
World Rank (Jul-30-2023)
6,790
Market Cap (Jul-30-2023)
1.532 Billion USD
World Rank (Dec-25-2022)
6,954
Market Cap (Dec-25-2022)
1.367 Billion USD
World Rank (Jan-07-2022)
6,108
Market Cap (Jan-07-2022)
2.10 Billion USD
Headquarters Country

BioCryst Pharmaceuticals

World Rank (Aug-2026)
5,615
Market Cap (Aug-2026)
2.489 Billion USD
World Rank (Jan-05-2024)
7,310
Market Cap (Jan-05-2024)
1.323 Billion USD
World Rank (Jul-30-2023)
7,021
Market Cap (Jul-30-2023)
1.451 Billion USD
World Rank (Dec-25-2022)
5,228
Market Cap (Dec-25-2022)
2.135 Billion USD
World Rank (Jan-07-2022)
6,134
Market Cap (Jan-07-2022)
2.08 Billion USD
Annual Revenue in USD
875 Million USD
Annual Operating Income in USD
341 Million USD
Annual Net Income in USD
264 Million USD
Annual Results for Period Ending
For year ending December-2025
Headquarters Country
Company Profile
BioCryst Pharmaceuticals is a Biotechnology company designs and develops small molecule medicines for rare diseases like hereditary angioedema (HAE) and fibrodysplasia ossificans progressive (FOP). The company annual revenue is 49 million USD and 140 employees as on 2019. The headquarters is in USA.

Share

Ads